Welcome to the Current Issues section of the Journal of Regulatory and Homecare Pharmacy (JRHP). Here, you can explore the latest research, reviews, and insights into regulatory practices, homecare pharmacy innovations, and related fields. Each issue is carefully curated to present the most relevant and impactful studies that contribute to the advancement of the profession.
Featured Articles in the Latest Issue
- Volume 2(Issue 2) JULY – DECEMBER 2025
Research Articles
The Medication Labeling Compliance in Homecare Settings: A Cross Sectional Regulatory Review
Vol.2(2); Pages:1-8. Published on October 2025
Abstract
Labeling of medication is a critical part in ensuring patient safety, especially in homecare settings, where the role of the professional in monitoring the patients is minimal. The aim of this research was to review the regulatory compliance of the medication labeling in prescriptions dispensed at home among community homecare and private homecare pharmacy in Portugal and France. Two hundred and fifty facilities were audited randomly out of which the number of medication packages audited was 410. The determination of the labels was done on the ground of local regulatory requirements and WHO standards of labeling, with particular attention to legibility, clarity of the name of the drug, the presence of an expiry date, patient-specific instructions, and auxiliary warning. The findings indicated that 62 per cent of the labels complied with all the regulatory requirements but most of them lacked storage directions and font sizes. areas that use automated labeling systems demonstrated an increase compliance rate. In interviewing the employees in the pharmacies, it was found that shortage of training and time pressure were primary factors that led to non-compliance. This paper presents the fact that there are a number of deficiencies in medication labeling issues during homecare delivery and identifies the importance of establishing standard labeling requirements, audits, and pharmacistbased interventions to promote patient safety and compliance with regulation.
View Full PDF
Please LOGIN to View Full PDF or Read more.
The effect of pharmacist-led medication reconciliation on Home-based palliative care and drug-related problems
Vol.2(2); Pages:9-18. Published on October 2025
Abstract
Patients receiving palliative care at home are the ones at a higher risk of drug-related problems (DRPs) because of polypharmacy, inadequate documentation and lack of monitoring. The proposed study Therefore, this proposed prospective interventional study sought to determine the effectiveness of pharmacist-led medication reconciliation in these patients to decrease DRPs among them. 95 patients in three regional networks of palliative care took part in a 6 week study. Baseline assessments revealed that most patients had an average of 3.2 DRPs, which involved therapeutic duplications, dosing errors, and changes in medications that were never documented. After the pharmacist reconciliation and partnership with caregivers, prescribers, and home nurses, the DRP rate dropped 53 percent. Most of the differences concerned the medications of pain management and adjuvant agents. There was a marked increase in caregiver satisfaction especially on the ability to understand the medication schedule. The intervention was cost-neutral and involved little changes in the workflow. Based on the findings, it will be crucial to consider the use of pharmacist-led medication reconciliation in homecare models in enhancing medication safety and patient care in vulnerable populations.
View Full PDF
Please LOGIN to View Full PDF or Read more.
Controlled Price, Risk Evaluation and Storage and Delivery of Cold Chain Medicines in Homecare pharmacy Services
Vol.2(2); Pages:19-28. Published on November 2025
Abstract
The rise in homecare pharmaceutical services has seen the rise in the demand of cold chain delivery of temperature-sensitive drugs such as insulin, monoclonal antibodies, and vaccines. The present paper assesses compliance risks and logistical risks related to the homecare traceability and stocks of those drugs. The assessment of the risk was applied following a systematic approach with references to WHO recommendations of the GDP and national regulations, in which 22 homecare pharmacies providers in Egypt and Southeast Asia were audited. The temperature data loggers were used to monitor 120 deliveries and it was found that 31 percent of them had temperature excursions greater than 15 minutes taken out of the 2-8 degree C range. The root cause analysis found some of the following problems: inadequate packaging, slow handoffs, and a lack of real time temperature monitoring. Also, forty eight percent of the providers had no formal SOPs governing cold chain breach. The research advises that cold chain providers should be mandatorily certified, IoT-based temperature monitors should be adopted and the regulatory provisions to be tightened to improve the compliance and ensure the safety of patients.
View Full PDF
Please LOGIN to View Full PDF or Read more.
Disposals of Pharmaceutical Wastes in Homecare: Compliance and Risk Assessments to Environment
Vol.2(2); Pages:29-38. Published on November 2025
Abstract
Non proper disposal of unused and expired drugs in homecare areas poses a great threat to the environment and health of the society. This research appraises the homecare pharmaceutical waste management practices in a sample size of 320 patients and caregivers in Switzerland and Sri Lanka with a view of auditing the adherence to the country pharmaceutical waste requirements. The research applied standard interviews, residential visit, and discard pharmaceutical samples analysis to determine the type, number, and the risks of environmental hazards. The results indicated that households only followed recommended modes of disposal by 38 per cent. The most widespread offenses were disposal of medicines into the toilet, the use of general waste, and reuse of the expired medications. The most prevalent misuse of antibiotics, NSAIDs, and hormonal agents was to dispose of them inappropriately causing serious pollution of the environment. Moreover 64% of the caregivers were not aware of take-back programs or regulatory guidelines of drugs. This paper reiterates the importance of pharmacist-based educational actions, compulsory take-back mechanisms on high-risk drugs, and better enforcement of regulations that may create a sustaining cycle of the management of pharmaceutical waste within homecare.
View Full PDF
Please LOGIN to View Full PDF or Read more.
Policy Analysis and Safety Issues of Directing Remote Dispensing device to Homecare Pharmacy: Opinion of the Regulating Authorities
Vol.2(2); Pages:39-48. Published on December 2025
Abstract
The fast-growing Remote Dispensing Systems (RDS), including the automated medication cabinets and virtual pharmacist consultations, have caused a transformation in the homecare pharmaceutical services. But the application of the systems still lacks coherence and regulation in most areas. The paper assesses homecare use of RDS in both countries, Brazil and Ghana, in terms of regulatory environment, patient safety impact as well as operational issues. The collection of data included semi-structured interviews of 20 regulatory officials, pharmacists, and technology vendors together with safety audits of 12 homecare centers by applying RDS platforms. Some of the main discoveries included variations in licensing, poor caregiver training and reporting of errors. Remarkably, 17 percent of prescriptions created by RDS were associated with minimal mislabeling or dosing consequences, most of which were misconfiguration of software-interface. In spite of this, RDS elevated medication access and compliance of homebound patients especially in rural sector to a great extent. To provide safe and scalable integration of digital pharmacy systems with homecare, the study proposes interconnected regulatory guidelines, the certification of technology, and regular remote auditing.
View Full PDF
Please LOGIN to View Full PDF or Read more.
Explore the full content of this issue to stay updated on the latest developments in regulatory and homecare pharmacy. Each article is available in full text and can be downloaded for further reading





